JLVIX
Price
$78.02
Change
-$0.45 (-0.57%)
Updated
Sep 20 closing price
VSTSX
Price
$269.69
Change
-$0.67 (-0.25%)
Updated
Sep 20 closing price
Ad is loading...

JLVIX vs VSTSX

Header iconJLVIX vs VSTSX Comparison
Open Charts JLVIX vs VSTSXBanner chart's image
JHancock Fundamental Large Cap Core I
Price$78.02
Change-$0.45 (-0.57%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Sel
Price$269.69
Change-$0.67 (-0.25%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JLVIX vs VSTSX Comparison Chart
Loading...
VS
JLVIX vs. VSTSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLVIX is a Buy and VSTSX is a Buy.

FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.72T vs. JLVIX (5.78B). VSTSX pays higher dividends than JLVIX: VSTSX (1.36) vs JLVIX (0.43). JLVIX was incepted earlier than VSTSX: JLVIX (24 years) vs VSTSX (8 years). JLVIX is a more actively managed with annual turnover of: 19.00 vs. VSTSX (2.00). JLVIX has a lower initial minimum investment than VSTSX: JLVIX (250000) vs VSTSX (5000000000). JLVIX (26.56) and VSTSX (25.91) have marching annual gain over last year. VSTSX return over 5 years is better than : 83.06 vs. JLVIX (64.21).
JLVIXVSTSXJLVIX / VSTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years8 years-
Gain YTD17.51816.934103%
Front LoadN/AN/A-
Min. Initial Investment25000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.78B1.72T0%
Annual Yield % from dividends0.431.3631%
Returns for 1 year26.5625.91102%
Returns for 3 years1.4821.397%
Returns for 5 years64.2183.0677%
Returns for 10 years95.43N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMAQX45.47-0.16
-0.35%
Principal MidCap R6
TIVRX29.40-0.12
-0.41%
Thornburg International Equity R5
VALAX28.41-0.14
-0.49%
Al Frank Adv
FTDZX159.16-0.92
-0.57%
Franklin Biotechnology Discovery Adv
MSSLX6.54-0.09
-1.36%
Morgan Stanley Inst Inception L